Past research on insider trading demonstrates that corporate insiders are very good at trading their companies’ stock, with the so-called informational pecking order allowing executives and Board members to generate strong trading profits. Similarly, research proves that outside investors can improve their portfolio returns by following insiders’ moves.
Nonetheless, insider trading metrics work better when combined with alternative stock analysis methods, meaning that those investors blindly following each insider sale and purchase may not do very well for themselves after all. While there is growing consensus of opinion on the theory that insider buying usually conveys positive information, the investment community does not agree on the statement that insider selling represents a bearish signal. Why? Because corporate insiders tend to sell shares for a wide range of reasons that may not be entirely related to their companies’ current conditions, so it’s practically impossible to know why an insider sells shares. Even so, keeping tabs on insider selling activity does make sense, as most insiders tend sell high and buy low quite frequently. Hence, this article will list three companies that had their insiders report insider selling with the SEC on the day Britain voted on whether to leave or stay in the European Union (better say, on the day Britons voted to leave the EU).
Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that imitating the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012 (read more details here).
huyangshu/Shutterstock.com
Managed Health Care Accounts Specialist Registers Heavy Insider Selling
Healthequity Inc. (NASDAQ:HQY) has seen increased insider selling in the past several months, but most insider selling was either related to freshly-exercised stock options or conducted under pre-arranged trading plans. So let’s have a look at the informative spur-of-the-moment insider selling only. Board member Michael O. Leavitt discarded 24,083 shares on Tuesday and 4,000 shares on Wednesday at prices varying from $29.05 to $29.37 per share. These shares were held directly by Third Chapter Inc., an entity controlled by Mr. Leavitt that continues to own 22,917 shares. Mr. Leavitt also holds a direct ownership stake of 30,000 shares.
The health savings account non-bank custodian has seen the value of its shares gain 16% since the beginning of 2016. The core of Healthequity Inc. (NASDAQ:HQY)’s business is the health savings account (HSA), a financial account consumers use to spend and save long-term for healthcare. The number of the company’s HSA members jumped by 51% year-over-year to 2.23 million at the end of April of 2016. The increase was partially driven by the acquisition of rights to be the custodian of the HSA portfolios acquired from The Bancorp Bank and M&T Bank. Meanwhile, the company recorded revenue of $44.0 million for the first quarter of fiscal 2017 that ended April 30, up from $29.9 million posted a year ago.
The number of hedge fund vehicles followed by Insider Monkey with equity positions in the managed health care accounts specialist dropped to 10 from 13 during the first quarter of 2016, whereas the value of those positions rose to $85.03 million from $66.37 million quarter-over-quarter. Israel Englander’s Millennium Management owned 445,554 shares of Healthequity Inc. (NASDAQ:HQY) at the end of March.
Follow Healthequity Inc. (NASDAQ:HQY)
Follow Healthequity Inc. (NASDAQ:HQY)
Let’s head to the next page of this article, where we will reveal fresh insider selling registered at two other companies.
